Uncovering the roots of Parkinson's disease, together
A global research initiative
Aligning Science Across Parkinson’s (ASAP) is fostering collaboration and resources to better understand the underlying causes of Parkinson’s disease. With scale, transparency, and open access data sharing, we believe we can accelerate the pace of discovery, and inform the path to a cure.
GP2 announced its 11th data release at the end of 2025, bringing the total to over 100,000 samples from individuals worldwide, making it one of the most comprehensive and globally representative PD datasets to date.
We are excited to share that we launched a new website to showcase the impact of our Collaborative Research Network (CRN) community and the role of the CRN in driving discoveries in Parkinson’s research.
We’re excited to share an update on recent advancements across the ASAP portfolio that fill critical knowledge gaps, promote the rapid dissemination of scientific insights, expand resource accessibility, and support the next generation of Parkinson’s researchers.
Latest News
GP2’s 11th Data Release
GP2 announced its 11th data release at the end of 2025, bringing the total to over 100,000 samples from individuals worldwide, making it one of the most comprehensive and globally representative PD datasets to date.
100,000 Participants and Counting – Massive Global Genetic Dataset Powers Discoveries in Parkinson’s Disease
Researchers have reached a major milestone in the effort to understand and treat Parkinson’s disease: more than 100,000 DNA samples from study participants around the world have now been genotyped and sequenced through the Global Parkinson’s Genetics Program (GP2).
ASAP Research Round-Up | Q3 2025
In this second edition of the ASAP Research Round-Up, ASAP shares advancements in Q2 2025 across the ASAP portfolio that fill critical knowledge gaps, promote rapid dissemination of scientific insights, expand resource accessibility, and support the next generation of Parkinson’s researchers.
